US EditionTransmural Systems Receives FDA 510(k) Clearance for Telltale
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Transmural Systems Receives FDA 510(k) Clearance for TELLTALE
ANDOVER, Mass.--(BUSINESS WIRE)--Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and Drug Administration (FDA) for TELLTALE – the first and only cleared and dedicated electrosurgical guidewire system to prevent coronary obstruction in patients undergoing Transcatheter Aortic Valve Replacement (TAVR) for both native aortic stenosis and [...] The post Tran…
Transmural Systems Receives FDA 510(k) Clearance for Telltale
ANDOVER, Mass.–(BUSINESS WIRE)–Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and Drug Administration (FDA) for TELLTALE – the first and only cleared and dedicated electrosurgical guidewire system to prevent coronary obstruction in patients undergoing Transcatheter Aortic Valve Replacement (TAVR) for both native aortic stenosis and bioprosthetic valve f…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
